Demy-Colton

?? Upcoming Virtual Salon, co-produced by Demy-Colton and EBD Group: TechBio Investor and Technology Trends at Biotech Showcase During Healthcare Week ?? Register Now: https://lnkd.in/ew5Sq_gP ?? Date: Wednesday, December 4, 2024 ?? Time: 11:00 AM - 12:15 PM ET (Inclusive of Q&A) Join us for an insightful virtual salon featuring a panel of TechBio CEOs, venture investors, and industry experts as they discuss the latest trends and innovations shaping the future of #humanhealth. This virtual salon will preview what’s to come during Biotech Showcase and Healthcare Week, January 13–15, 2025, in San Francisco. ??? Moderator:? - Lila Taylor, CBO, Demy-Colton ?? Featured Panel:? - Jessica Davis, Principal, AVANT BIO? - Marine Mallinson, Venture Advisor, Noetic Fund - David "DSO" Suendermann-Oeft, Founder & CEO, Modality.AI?? - Jan Van den Berghe, Co-Founder, Novalis Biotech Fund - Alla Zamarayeva, PhD, CEO, CellFE? ? Register now to reserve your spot! ?? https://lnkd.in/gn-A6KqK ?? Ready to showcase your innovation? Explore Biotech Showcase 2025 presentation opportunities here: https://lnkd.in/eFR_37pZ #BiotechShowcase #DemyColton #Innovation #Partnering #BiotechNetworking #TechBio #HealthcareWeek EBD Group

We're thrilled to have CellFE's CEO Alla Zamarayeva, PhD join upcoming TechBio Investor and Technology Trends panel this year! Join the Virtual Salon on Wednesday, Dec 4th at 11AM EST as panelists discuss cutting-edge technology that is shaping the future of cell and gene therapy to improve healthcare outcomes. Register to reserve your spot: ?? https://lnkd.in/ew5Sq_gP Schedule a meeting at Biotech Showcase 2025: ?? https://lnkd.in/eynMeaR Demy-Colton EBD Group #BiotechShowcase #Innovation #CellTherapy #NonViral #TechBio #CGT

?? Exciting news! We’re thrilled to announce additional speakers for our upcoming virtual salon. Join us next week for the "TechBio Investor and Technology Trends at Biotech Showcase During Healthcare Week," co-produced by Demy-Colton and EBD Group. ?? Register Now: https://lnkd.in/ew5Sq_gP ?? Date: Wednesday, December 4, 2024 ?? Time: 11:00 AM - 12:15 PM ET (Inclusive of Q&A) Be part of an insightful virtual salon featuring a panel of TechBio CEOs, venture investors, and industry experts as they discuss the latest trends and innovations shaping the future of #humanhealth. This session will also offer a preview of what’s to come during Biotech Showcase and Healthcare Week, January 13–15, 2025, in San Francisco. ??? Moderator:? - Lila Taylor, CBO, Demy-Colton ?? Featured Panel:? - Jessica Davis, Principal, AVANT BIO? - Marine Mallinson, Venture Advisor, Noetic Fund - David "DSO" Suendermann-Oeft, Founder & CEO, Modality.AI?? - Jan Van den Berghe, Co-Founder, Novalis Biotech Fund - Alla Zamarayeva, PhD, CEO, CellFE? ? Register now to join us! ?? https://lnkd.in/gn-A6KqK ?? Interested in showcasing your innovation? Explore Biotech Showcase 2025 opportunities here: https://lnkd.in/eFR_37pZ #BiotechShowcase #DemyColton #Innovation #Partnering #BiotechNetworking #TechBio #HealthcareWeek

?? During the #BioFuture2024 conference, Genetic Engineering & Biotechnology News interviewed Xiaorong He, PhD, Senior Vice President, Site Head Development U.S. and Head of Global Development Sciences, Boehringer Ingelheim. Their conversation explored various topics, including virtual clinical trials, predictive modeling, and the potential of AI to enhance success rates and improve patient outcomes. Dr. He provided valuable insights into Boehringer’s collaborations with Ten63 Therapeutics and Phenomic, which aim to advance drug discovery and address complex diseases. She highlighted the importance of innovative tools like ADAM for molecule design and IQNow, an AI-powered knowledge management platform that has collectively saved over 116 years of time across the organization. ?? Read the full interview here:?https://lnkd.in/gWZtDYGg We’re excited to continue this conversation at #BiotechShowcase and explore how #AI will shape the future of pharma and drug development. Thank you, Genetic Engineering & Biotechnology News, for facilitating this insightful discussion with Dr. He about the transformative impact of #AI in the industry! #BioFuture #LifeSciences #Innovation #Biotech #Biopharma #AI #DigitalHealth #DrugDevelopment #Therapeutics #TechBio #VCFunding #Investors #Partnering #DemyColton

?? Beech Biotech SA Presenting at Biotech Showcase?! Ian Cottingham, CEO of Beech Biotech, will present the company’s platform technology that repurposes clinically validated antibodies for treating diseases of pregnancy, starting with #preeclampsia, a severe unmet medical need.?As a private company based in Lausanne, Switzerland, Beech Biotech’s therapeutic focus areas are women’s health and antibodies.? ? ??? Register to attend and learn more: https://lnkd.in/etBBXuS7 Biotech Showcase, alongside Seed Showcase and TechBio Showcase, provides private and micro- to mid-cap biotechnology companies with a premier platform to present their innovations directly to investors and biopharmaceutical executives. Join us in San Francisco, January 13–15, 2025, with virtual sessions on January 16–17 on the partneringONE platform, to showcase your organization and connect with strategic partners. ?? Apply to present your innovations: https://lnkd.in/ekcG2ntx? ?? What to Expect at Biotech Showcase: https://lnkd.in/e87uBu3R? #BiotechShowcase #DemyColton #EBDGroup #Biotech #WomensHealth #Antibodies #Innovation #Investors #Partnering #BeechBiotech EBD Group

?? Atom Bioworks Presenting at Biotech Showcase?! Sherwood Yao, CEO of Atom Bioworks, will present on the company’s use of?AI to design aptamer-based ligand to target immune and cancer cell receptors for specific cell and gene therapy delivery.?Based in Cary, North Carolina, Atom Bioworks is a private company focused on AI-driven solutions for advancing cell and gene therapy. ??? Register to attend and learn more: https://lnkd.in/e73Z6jgc? Biotech Showcase, alongside Seed Showcase and TechBio Showcase, provides private and micro- to mid-cap biotechnology companies with a premier platform to present their innovations directly to investors and biopharmaceutical executives. Join us in San Francisco, January 13–15, 2025, with virtual sessions on January 16–17 on the partneringONE platform, to showcase your organization and connect with strategic partners. ?? Apply to present your innovations: https://lnkd.in/evsna3kD? ?? What to Expect at Biotech Showcase: https://lnkd.in/epFyfyV7? #BiotechShowcase #DemyColton #EBDGroup #Biotech #AI #CellTherapy #GeneTherapy #DrugDelivery #Innovation #Investors #Partnering #AtomBioworks?Demy-Colton EBD Group

???? partneringONE? for Biotech Showcase is now open! Biotech Showcase? is just weeks away, taking place in San Francisco from January 13–15, 2025. This is the perfect opportunity to start scheduling your one-to-one meetings. partneringONE? provides the tools you need to connect with investors and potential partners during the most important fundraising week of the year. Request meetings today to avoid scheduling conflicts and secure key conversations that could shape your next breakthrough. ??? Register now and learn more: https://lnkd.in/esQqbqxa #BiotechShowcase #partneringONE #Networking #Investors #Biotech #Innovation #DemyColton #EBDGroup

?? Artery Therapeutics, Inc. Presenting at Biotech Showcase?! Jan Johansson, CEO & Founder of Artery Therapeutics, Inc., will present on the company’s work on ABCA1 transporter and APOE4-driven dementias, including #Alzheimers and #orphannerve diseases. As a Phase 1-2 stage biotech, Artery Therapeutics is looking for collaborations or partnering to advance the CS6253 lead. Based in San Ramon, California, the company’s therapeutic focus is?CNS/neurological diseases, longevity, and neuropathy/pain. ??? Register to attend and learn more: https://lnkd.in/eJyJJuQa? Biotech Showcase, alongside Seed Showcase and TechBio Showcase, provides private and micro- to mid-cap biotechnology companies with a premier platform to present their innovations directly to investors and biopharmaceutical executives. Join us in San Francisco, January 13–15, 2025, with virtual sessions on January 16–17 on the partneringONE platform, to showcase your organization and connect with strategic partners. ?? Apply to present your innovations: https://lnkd.in/emszbpGp? ?? What to Expect at Biotech Showcase: https://lnkd.in/eE8dK4KV? #BiotechShowcase #DemyColton #EBDGroup #Biotech #CNS #Longevity #Neuropathy #DrugDiscovery #Innovation #Investors #Partnering #ArteryTherapeutics?EBD Group Demy-Colton

?? Alveolus Bio Presenting at Biotech Showcase?! Gaurav Mehta, CEO of Alveolus Bio, will present on the company’s lead asset targets neutrophilic inflammation, a common factor in?#lungdiseases?like COPD, BPD (orphan designation), and severe asthma. With positive pre-IND FDA feedback, publication in Nature, and a $2.3M NIH fast-track SBIR grant, Alveolus Bio is preparing to enter clinical trials. The breadth of the company's IP also opens possibilities for applications beyond lung disease, including CNS therapies. ??? Register to attend and learn more: https://lnkd.in/eDhypqGH? Biotech Showcase, alongside Seed Showcase and TechBio Showcase, provides private and micro- to mid-cap biotechnology companies with a premier platform to present their innovations directly to investors and biopharmaceutical executives. Join us in San Francisco, January 13–15, 2025, with virtual sessions on January 16–17 on the partneringONE platform, to showcase your organization and connect with strategic partners. ?? Apply to present your innovations: https://lnkd.in/eWGhPBKy? ?? What to Expect at Biotech Showcase: https://lnkd.in/eMZvQ6Ub? #BiotechShowcase #DemyColton #EBDGroup #Biotech #PulmonaryHealth #Inflammation #DrugDiscovery #Innovation #Investors #Partnering #AlveolusBio?Demy-Colton EBD Group

?? Aegle Therapeutics Presenting at Biotech Showcase?!? ? Shelley A. Hartman, CEO of Aegle Therapeutics,?will present on the company’s work in Immunology, Inflammation, and Orphan/Rare Diseases. Founded in 2018 as a private company, Aegle Therapeutics is advancing a clinical trial for recessive dystrophic Epidermolysis Bullosa (#RDEB), a rare and challenging condition. Early clinical data with their lead candidate, AGLE-102, shows promising potential for regenerative healing, including dermal remodeling of chronic RDEB wounds with significant scarring. AGLE-102 utilizes extracellular vesicles derived from MSCs to drive impactful healing in patients. ??? Register to attend and learn more: https://lnkd.in/evchNnAj? Biotech Showcase, alongside Seed Showcase and TechBio Showcase, provides private and micro- to mid-cap biotechnology companies with a premier platform to present their innovations directly to investors and biopharmaceutical executives. Join us in San Francisco, January 13–15, 2025, with virtual sessions on January 16–17 on the partneringONE platform, to showcase your organization and connect with strategic partners. ?? Apply to present your innovations: https://lnkd.in/e449f9Zg ?? What to Expect at Biotech Showcase: https://lnkd.in/eudKKs_2? #BiotechShowcase #DemyColton #EBDGroup #Biotech #Immunology #Inflammation #RareDisease #Innovation #Investors #Partnering #AegleTherapeutics?Demy-Colton EBD Group